RAZA SAIYED ATIQ sold $314K of AIP (indirect holdings)
RAZA SAIYED ATIQ sold 8,332 indirectly-held shares of Arteris, Inc. (AIP) at $37.65 ($0.31M total) on 2026-06-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The main tradable element is sentiment around insider activity; however, 10b5-1 typically dampens interpretive value versus non-plan sales.
Market read
AIP saw disclosed director selling (~$314K) under a 10b5-1 plan; this is more of a sentiment datapoint than a fundamental catalyst.
What to watch
10b5-1 plans are often used for routine liquidity; the filing does not reveal intent beyond the pre-set schedule, and the article provides no follow-on guidance or performance change.
Background
The filing is an SEC Form 4 insider transaction (director) for Arteris, Inc., reporting an open-market sale executed under a Rule 10b5-1 plan.
Ticker impact
Arteris director RAZA SAIYED ATIQ sold 8,332 shares in an open-market transaction under a 10b5-1 plan, disclosing $313,733.96 proceeds.
Likely limited near-term price impact; any reaction should fade unless accompanied by other fundamental news.
This is an SEC Form 4 insider transaction with a pre-arranged 10b5-1 plan; it is a disclosed datapoint but not a new operating/financial catalyst.
Market effects
Minimal—single-company insider transaction without sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
If the market interprets director selling as a stronger-than-expected risk signal, short-term downside pressure could occur despite the 10b5-1 label.
Key entities
- issuerArteris, Inc.
Subject of the Form 4 insider transaction; director sold shares under a 10b5-1 plan.
- insiderRAZA SAIYED ATIQ
Director who executed the open-market sale disclosed in the Form 4.
